Pickup In Korea Biopharma IPO Activity Signals Improving Investor Sentiment

 
• By Jung Won Shin
  
market recovery
South Korea's D&D Pharmatech, ENCell See Strong IPO Demand (Shutterstock)

More from Focus On Asia

More from Business